Skip to main content
. Author manuscript; available in PMC: 2013 Sep 1.
Published in final edited form as: Diabetologia. 2012 Jun 4;55(9):2533–2545. doi: 10.1007/s00125-012-2594-1

Fig. 5.

Fig. 5

Activation of STAT3 is required for ER stress-mediated inflammation in TR-iBRB cells. (a) TR-iBRB cells were treated with TM (50 ng/ml) or TG (10 nmol/l) for 8 h, and levels of phosporylated STAT3 (p-STAT3; black bars) and total STAT3 (t-STAT3; white bars) were determined by western blot analysis and quantified by densitometry (mean±SD, n=3). (bd) TR-iBRB cells were pretreated with cucurbitacin I (Cu I) for 1 h, followed by treatment with 10 nmol/l TG for 8 h. Levels of ICAM-1, TNF-α and VEGF were determined by western blot analysis and quantified by densitometry (mean±SD, n=3). **p<0.01 vs control; p<0.05, ††p<0.01 vs TG group. (eh) STAT3 was knocked down using siRNA (Stat3i), followed by treatment with 10 nmol/l TG for 8 h. Ctrli: scrambled/control siRNA. Knockdown efficiency was assessed from the protein level of STAT3 in cells transfected with Stat3i or transfectant only (e). Levels of ICAM-1, TNF-α and VEGF were determined by western blot analysis and quantified by densitometry (fh, mean±SD, n=3). **p<0.01 vs Ctrli; ††p<0.01 vs Ctrli+TG